Jure Pohleven

921 citations
16 papers · 678 indexed · h-index 13
Topics
Toxin Mechanisms and Immunotoxins (5 papers)Glycosylation and Glycoproteins Research (4 papers)Fungal Biology and Applications (4 papers)

In The Last Decade

Jure Pohleven

16 papers receiving 638 citations

Peers

Jure Pohleven
Comparison fields: 5 of 85
  • Molecular Biology 331
  • Pharmacology 242
  • Plant Science 207
  • Immunology 115
  • Biotechnology 71
Replace Jianlin Chen with:
Jianlin Chen China
Yating Dong China
Vladimir J. Cvetković Serbia
Tingting Sun China
Felipe S. Chambergo Brazil
Wànkuí Gǒng China
Dipali Rani Gupta Bangladesh
Hao Shuxian China
Tianlun Zhao China
Jure Pohleven relative to Jianlin Chen China Jianlin Chen's profile →
Citations per field
00.5×3.3×
Jianlin Chen · 1×
Citations per year

Countries citing papers authored by Jure Pohleven

Since Specialization
Citations

This map shows the geographic impact of Jure Pohleven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jure Pohleven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jure Pohleven more than expected).

Fields of papers citing papers by Jure Pohleven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jure Pohleven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jure Pohleven. The network helps show where Jure Pohleven may publish in the future.

Co-authorship network of co-authors of Jure Pohleven

This figure shows the co-authorship network connecting the top 25 collaborators of Jure Pohleven. A scholar is included among the top collaborators of Jure Pohleven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jure Pohleven. Jure Pohleven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 35
2 50
3 4
4 1
5 9
6 17
7 58
8 33
9 23
10 54
11 40
12 23
13 87
14 90
15
Cultivation Techniques and Medicinal Properties of Pleurotus spp.
126
16 28

About Jure Pohleven

Jure Pohleven is a scholar working on Immunology, Pharmacology and Pharmacology, having authored 16 papers that have together received 678 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Fungal Biology and Applications (4 papers). The work is most often cited by research in Pharmacology (242 citations), Biotechnology (71 citations) and Pharmacology (68 citations). Jure Pohleven has collaborated with scholars based in Slovenia, Switzerland and Croatia. Frequent co-authors include Andrej Gregori, Jerica Sabotič, Janko Kos, Borut Štrukelj, Jože Brzin, Michael Burnard, Markus Künzler, Andreja Kutnar, Kristina Sepčić and Silvia Bleuler‐Martinez. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026